Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Apr 6;13(4):641-649.
doi: 10.2215/CJN.10440917. Epub 2018 Jan 2.

Treatment of Severe Hyponatremia

Affiliations
Review

Treatment of Severe Hyponatremia

Richard H Sterns. Clin J Am Soc Nephrol. .

Abstract

Patients with severe (serum sodium ≤120 mEq/L), symptomatic hyponatremia can develop life-threatening or fatal complications from cerebral edema if treatment is inadequate and permanent neurologic disability from osmotic demyelination if treatment is excessive. Unfortunately, as is true of all electrolyte disturbances, there are no randomized trials to guide the treatment of this challenging disorder. Rather, therapeutic decisions rest on physiologic principles, animal models, observational studies, and single-patient reports. European guidelines and recommendations of an American Expert panel have come to similar conclusions on how much correction of hyponatremia is enough and how much is too much, but there are important differences. We review the evidence supporting these recommendations, identifying areas that rest on relatively solid ground and highlighting areas in greatest need of additional data.

Keywords: Animal; Animals; Brain Edema; Demyelinating Diseases; Models; Osmosis; Sodium; United States; Water-Electrolyte Imbalance; clinical nephrology; electrolytes; humans; hypokalemia; hyponatremia; osmolality.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
In a cohort of chronically hyponatremic patients with serum sodium concentrations ≤105 mEq/L, post-therapeutic (post-Rx) neurological complications occurred after correction by >12 mEq/L in 24 hours and >18 mEq/L in 48 hours. Patients with chronic hyponatremia refers to patients without psychotic polydipsia who became hyponatremic at home. Solid circles represent patients with post-therapeutic neurologic complications, and open triangles represent patients who recovered uneventfully. The dashed lines represent therapeutic limits identified by the study (12 mEq/L in 24 hours and 18 mEq/L in 48 hours). Modified from ref. , with permission.
Figure 2.
Figure 2.
Limits for safe correction are difficult to define when the serum sodium concentration is extremely low. This patient presented with mild symptoms despite a serum sodium of 100 mEq/L. Beginning on the third day after correction by 8 mEq/L per day, the patient developed new progressive symptoms, including dysphasia, psychosis, and dyskinetic movements consistent with a diagnosis of osmotic demyelination syndrome. However, the symptoms resolved spontaneously, and magnetic resonance imaging was negative. D, day; GCS, Glascow coma scale. Reprinted from ref. , with permission.
Figure 3.
Figure 3.
Most, but not all patients with osmotic demyelination associated with both hypokalemia and hyponatremia and documented by autopsy or magnetic resonance imaging had undergone correction by >10 mEq/L in 24 hours and >18 mEq/L in 48 hours. Patients were identified by a literature review, and they were included if data on sodium correction in the first 24 and 48 hours were provided. Dashed lines represent proposed limits of 10 mEq/L in 24 hours and 18 mEq/L in 48 hours. Modified from ref. , with permission.

Comment in

  • Commentary on Treatment of Severe Hyponatremia.
    Seliger S, Kestenbaum B. Seliger S, et al. Clin J Am Soc Nephrol. 2018 Apr 6;13(4):650-651. doi: 10.2215/CJN.13381217. Epub 2018 Jan 2. Clin J Am Soc Nephrol. 2018. PMID: 29295827 Free PMC article. No abstract available.

Similar articles

Cited by

References

    1. Spasovski G, Vanholder R, Allolio B, Annane D, Ball S, Bichet D, Decaux G, Fenske W, Hoorn EJ, Ichai C, Joannidis M, Soupart A, Zietse R, Haller M, van der Veer S, Van Biesen W, Nagler E; Hyponatraemia Guideline Development Group: Clinical practice guideline on diagnosis and treatment of hyponatraemia. Nephrol Dial Transplant 29[Suppl 2]: i1–i39, 2014 - PubMed
    1. Verbalis JG, Goldsmith SR, Greenberg A, Korzelius C, Schrier RW, Sterns RH, Thompson CJ: Diagnosis, evaluation, and treatment of hyponatremia: Expert panel recommendations. Am J Med 126[Suppl 1]: S1–S42, 2013 - PubMed
    1. Sterns RH, Hix JK, Silver S: Treating profound hyponatremia: A strategy for controlled correction. Am J Kidney Dis 56: 774–779, 2010 - PubMed
    1. Ayus JC, Olivero JJ, Frommer JP: Rapid correction of severe hyponatremia with intravenous hypertonic saline solution. Am J Med 72: 43–48, 1982 - PubMed
    1. Sterns RH, Nigwekar SU, Hix JK: The treatment of hyponatremia. Semin Nephrol 29: 282–299, 2009 - PubMed